INSIG AI PLC — Director's Dealing 2026

Apr 22, 2026

National Storage Mechanism | Additional information

RNS Number : 3892B

Insig AI Plc

22 April 2026

22 April 2026

Insig AI plc

("Insig AI" or the "Company")

Equity Subscription, Total Voting Rights and PDMR Dealings

On 1 April 2026, the Company announced that the Board had received an expression of interest from Richard Bernstein, Chief Executive, to invest £0.5 million in equity at 20p per share, a substantial premium to the prevailing share price.

On 1 April 2026, the Company also announced it has evaluated over 100 digital asset investment opportunities, with a focus on identifying ventures with the capacity to deliver exceptional returns for shareholders. The Company noted that some of these discussions are more advanced than others and in recent weeks, these discussions have continued to progress.

Whilst Richard Bernstein remains interested in investing £0.5 million, the Board has resolved to accept an initial £250,000 of equity funding from Richard Bernstein. These funds will be used for general working capital purposes and potentially into a specific digital asset investment that meets the Company's investment criteria.

This equity investment is deemed to be an AIM Rule 13 'Related Party Transaction'.  The directors of the Company excluding Richard Bernstein, deem the terms to be fair and reasonable. Richard Bernstein will now subscribe for 1,250,000 new ordinary shares at 20p per share (the "Subscription"). This subscription price represents a premium of 21.2% to the closing share price of 16.5 pence on 21 April 2026.

Following the Subscription, Richard Bernstein's beneficial interest in the Company will total 22,250,000 ordinary shares ("Subscription Shares"), which represents 17.63% of Insig AI's enlarged total voting rights.

Admission and Total Voting Rights

Application will be made to the London Stock Exchange for admission of the Subscription Shares to trading on AIM ("Admission"). Admission is expected to become effective, and dealings in the Subscription Shares are anticipated to commence on or around 27 April 2026.

Following Admission, the issued share capital and total voting rights of the Company will be 126,212,212. Shareholders may use this figure as the denominator to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Richard Bernstein, Chief Executive of Insig AI, commented:

"This is an exciting time for the business. I am pleased to be increasing my investment."

For further information, please visit www.insig.ai or contact:

Insig AI plc
Richard Bernstein	[email protected]
Zeus (Nominated Adviser & Broker)
David Foreman / James Hornigold	+44 (0)20 3829 5000
CMC Markets Joint Broker
Doug Crippin	+44 (0)20 3003 8632

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Richard Bernstein
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Insig AI plc
b)	LEI	21380098CKBAG1NWCD98
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 1 pence each
Identification code	GB00BYV31355
b)	Nature of the transaction	Equity Subscription
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		20.00p	1,250,000
d)	Aggregated information	As above
- Aggregated volume
- Price
e)	Date of the transaction	21 April 2026
f)	Place of the transaction	London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSEFESFEMSEDL